Bio-Rad Laboratories | BIO - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.07B 252M 2026-03
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bio Techne USD 2.55B 27.9M 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Charles River Laboratories USD 7.73B 594.89M 2026-03
Danaher USD 83.54B 80M 2026-03
General Electric Aerospace USD 128.45B 1.72B 2026-03
Illumina USD 6.56B 85M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Merck USD 128.68B 8.18B 2026-03
Mettler Toledo International USD 3.67B 43.73M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
OraSure Technologies USD 379.17M 24M 2026-03
Pacific Biosciences Of California USD 782.36M 1.72M 2026-03
Quest Diagnostics USD 16.67B 448M 2026-03
Repligen USD 2.93B 18.93M 2026-03
Revvity USD 12B 171.82M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Siemens EUR 167.97B 2.16B 2026-03
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Tosoh JPY 1.41T 64.61B 2026-03
Waters USD 24.53B 19.45B 2026-03